Pancreatic Insufficiency Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Pancreatic Insufficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 4

THE MALABSORPTION BLOOD TEST TRIAL WILL HELP DETERMINE THE BENEFITS OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH MILD TO MODERATE EXOCRINE PANCREATIC INSUFFICIENCY.

Chronic PancreatitisExocrine Pancreatic InsufficiencyRecurrent Acute Pancreatitis
Anna Evans Phillips80 enrolled2 locationsNCT07418593
Recruiting
Not Applicable

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

Exocrine Pancreatic InsufficiencyMulti Organ Failure
Inova Health Care Services32 enrolled1 locationNCT05710315
Recruiting
Not Applicable

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Cystic FibrosisPancreatic Insufficiency
University of Pennsylvania45 enrolled1 locationNCT01851694
Recruiting
Phase 1

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

Cystic Fibrosis-related DiabetesPancreatic Insufficiency
University of Pennsylvania15 enrolled2 locationsNCT06995651
Recruiting
Phase 4

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency
Ohio State University60 enrolled5 locationsNCT06477159
Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Myelodysplastic SyndromesShwachman-Diamond SyndromeSDS+24 more
Shwachman-Diamond Syndrome Alliance Inc8,000 enrolled1 locationNCT06999954
Recruiting
Phase 2

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Cystic FibrosisDiabetesPancreatic Insufficiency+1 more
University of Pennsylvania30 enrolled2 locationsNCT04731272
Recruiting
Phase 3

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

PancreatitisExocrine Pancreatic Insufficiency (EPI)
Massachusetts General Hospital60 enrolled1 locationNCT06691893
Recruiting

MS1819-SD phase IIa clinical trial for patients with exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP) and/or distal pancreatectomy.

Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP)Exocrine pancreatic insufficiency (EPI) caused by distal pancreatectomy.
INC Research Australia Pty Ltd13 enrolled6 locationsACTRN12616000962437